We are live on ! Find out more
MEDP icon

Medpace

583 hedge funds and large institutions have $8.47B invested in Medpace in 2024 Q3 according to their latest regulatory filings, with 70 funds opening new positions, 246 increasing their positions, 198 reducing their positions, and 106 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more repeat investments, than reductions

Existing positions increased: 246 | Existing positions reduced: 198

0.43% less ownership

Funds ownership: 82.37%81.94% (-0.43%)

6% less funds holding

Funds holding: 623583 (-40)

18% less capital invested

Capital invested by funds: $10.4B → $8.47B (-$1.9B)

34% less first-time investments, than exits

New positions opened: 70 | Existing positions closed: 106

46% less funds holding in top 10

Funds holding in top 10: 137 (-6)

79% less call options, than puts

Call options by funds: $14.8M | Put options by funds: $71M

Holders
583
Holders Change
-40
Holders Change %
-6.42%
% of All Funds
8.37%
Holding in Top 10
7
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-46.15%
% of All Funds
0.1%
New
70
Increased
246
Reduced
198
Closed
106
Calls
$14.8M
Puts
$71M
Net Calls
-$56.1M
Net Calls Change
-$38.5M
Name Holding Trade Value Shares
Change
Change in
Stake
Arrowstreet Capital
26
Arrowstreet Capital
Massachusetts
$72.7M -$7.48M -19,697 -8%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$69.6M -$34.7M -91,324 -30%
Loomis, Sayles & Company
28
Loomis, Sayles & Company
Massachusetts
$68.7M +$5.27M +13,880 +7%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$67.5M -$9.11M -23,979 -11%
Franklin Resources
30
Franklin Resources
California
$66.5M +$11.6M +30,530 +19%
Charles Schwab
31
Charles Schwab
California
$66.4M -$2.88M -7,576 -4%
ITP
32
Iron Triangle Partners
Connecticut
$64.4M +$73.3M +192,842 New
Ameriprise
33
Ameriprise
Minnesota
$63.6M +$12.9M +33,990 +22%
Two Sigma Advisers
34
Two Sigma Advisers
New York
$62.9M +$3.08M +8,100 +4%
EAM
35
Eagle Asset Management
Florida
$59.4M -$41.8M -110,026 -40%
JP Morgan Chase
36
JP Morgan Chase
New York
$58.5M +$4.73M +12,455 +8%
JAM
37
Jupiter Asset Management
United Kingdom
$57.8M -$268K -705 -0.4%
Bank of America
38
Bank of America
North Carolina
$56M +$6.78M +17,852 +12%
Los Angeles Capital Management
39
Los Angeles Capital Management
California
$54.9M -$15.5M -40,707 -20%
DDC
40
DF Dent & Co
Maryland
$53.8M +$40.1M +105,659 +190%
Skandinaviska Enskilda Banken (SEB)
41
Skandinaviska Enskilda Banken (SEB)
Sweden
$53.3M +$7.56M +19,900 +14%
Allspring Global Investments
42
Allspring Global Investments
North Carolina
$51.1M +$13.9M +36,473 +31%
Two Sigma Investments
43
Two Sigma Investments
New York
$48.7M +$8.45M +22,232 +18%
GKIM
44
GW&K Investment Management
Massachusetts
$47.4M -$11.2M -29,445 -17%
SCM
45
Spyglass Capital Management
California
$47.4M +$12.3M +32,466 +30%
SEI Investments
46
SEI Investments
Pennsylvania
$47.2M +$5.52M +14,532 +11%
T. Rowe Price Associates
47
T. Rowe Price Associates
Maryland
$43.9M -$8.64M -22,755 -15%
BTW
48
Boston Trust Walden
Massachusetts
$43.3M -$10.7M -28,296 -18%
CCM
49
Camber Capital Management
Massachusetts
$41.7M +$47.5M +125,000 New
Fisher Asset Management
50
Fisher Asset Management
Washington
$41.5M +$3.04M +8,012 +7%

MEDP Hedge Fund Activity: Q3 2024 in Review

583 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q3 2024, worth a combined $8.47B — down 18% from $10.4B a quarter earlier.

Sellers outnumbered buyers: 106 funds closed out of MEDP and 70 opened new positions — a net loss of 36 holders — while 198 trimmed existing stakes and 246 added.

The largest buyer was Capital World Investors, adding an estimated $166M. The largest seller was Westwind Capital, cutting an estimated $132M.

  • 583 institutional investors held Medpace (MEDP) as of Q3 2024, down from 623 in Q2 2024.
  • Funds reported $8.47B of Medpace stock for Q3 2024, down 18% quarter-over-quarter.
  • 70 funds opened new Medpace positions in Q3 2024 and 106 closed out, a net change of -36 holders.
  • The largest Medpace buyer in Q3 2024 was Capital World Investors, an estimated $166M added.
  • The largest Medpace seller in Q3 2024 was Westwind Capital, an estimated $132M sold.

Based on aggregated 13F filings for Q3 2024.